BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Poulis N, Zaytseva P, Gähwiler EKN, Motta SE, Fioretta ES, Cesarovic N, Falk V, Hoerstrup SP, Emmert MY. Tissue engineered heart valves for transcatheter aortic valve implantation: current state, challenges, and future developments. Expert Review of Cardiovascular Therapy 2020;18:681-96. [DOI: 10.1080/14779072.2020.1792777] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Gasek N, Dearborn J, Enes SR, Pouliot R, Louie J, Phillips Z, Wrenn S, Uhl FE, Riveron A, Bianchi J, Commins SP, Delance N, Taatjes DJ, Boyson JE, Guthrie K, Petersen TH, Weiss DJ. Comparative immunogenicity of decellularized wild type and alpha 1,3 galactosyltransferase knockout pig lungs. Biomaterials 2021;276:121029. [PMID: 34311317 DOI: 10.1016/j.biomaterials.2021.121029] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Kwon JH, Hill MA, Gerry B, Morningstar J, Kavarana MN, Nadig SN, Rajab TK. Cellular Viability of Partial Heart Transplant Grafts in Cold Storage. Front Surg 2021;8:676739. [PMID: 34327211 DOI: 10.3389/fsurg.2021.676739] [Reference Citation Analysis]
3 Gähwiler EKN, Motta SE, Martin M, Nugraha B, Hoerstrup SP, Emmert MY. Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering. Front Cell Dev Biol 2021;9:639699. [PMID: 34262897 DOI: 10.3389/fcell.2021.639699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Qi SS, Kelly RF, Bianco R, Schoen FJ. Increased utilization of bioprosthetic aortic valve technology:Trends, drivers, controversies and future directions. Expert Rev Cardiovasc Ther 2021;19:537-46. [PMID: 33928833 DOI: 10.1080/14779072.2021.1924676] [Reference Citation Analysis]